Adaptimmune Snags FDA Nod For TCR Therapy Tecelra

 
• By Alaric DeArment
  
Adaptimmune received accelerated approval from the FDA for its TCR therapy, Tecelra • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip